Outcomes from the March 2021 PBAC set for public release

MAESTrO Database

23 April 2021 - The outcome are set to be published later today; what will they reveal?

We know the agenda for the March 2021 meeting was revised/updated four times. Has it been revised yet again? 

Will we see an outcome for onasemnogene abeparvovec (Zolgensma) which was deferred in November 2020 but is not in the published agenda for the March 2021 meeting?  Will risdiplam (Evrysdi) be recommended before Zolgensma?

Has the PBAC recommended Trikafta?

Full analysis in Monday's issue of MAESTrO Daily.

Michael Wonder

Posted by:

Michael Wonder